Authors: Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J PMID: 33959278 PMCID: PMC8060761 DOI: 10.1177/20499361211009385 Abstract Coronavirus disease 2019 (COVID-19) is a viral infection which can cause a variety of respiratory, gastrointestinal, and vascular symptoms. The acute illness phase generally lasts no more than 2-3 weeks. However, there is increasing evidence that a proportion of [...]

Authors: Wood E, Hall KH, Tate W PMID: 33251031 PMCID: PMC7680046 DOI: 10.1016/j.cdtm.2020.11.002 Abstract A significant number of SARS-CoV-2 (COVID-19) pandemic patients have developed chronic symptoms lasting weeks or months which are very similar to those described for myalgic encephalomyelitis/chronic fatigue syndrome. This study reviews the current literature and understanding of the role that mitochondria, [...]

Authors: Nicolson GL, Rosenblatt S, de Mattos GF, Settineri R, Breeding PC, Ash ME PMID: 32309576 PMCID: PMC6941554 DOI: 10.15190/d.2016.1 Abstract Membrane Lipid Replacement is the use of functional oral supplements containing cell membrane glycerolphospholipids and antioxidants to safely replace damaged membrane lipids that accumulate during aging and in various chronic and acute diseases. Most [...]

Authors: Booth NE, Myhill S, McLaren-Howard J PMID: 22837795 PMCID: PMC3403556 Abstract The objectives of this study are to test the hypothesis that the fatigue and accompanying symptoms of Chronic Myalgic Encephalomyelitis/Fatigue Syndrome are in part due to defects in energy provision at the cellular level, and to understand the pathophysiology of the defects so [...]

Authors: Nicolson GL, Settineri R, Ellithorpe R DOI: 10.4236/ijcm.2012.33034 Abstract Objectives: A preliminary open label study was initiated to determine if a combination oral supplement containing a mixture of phosphoglycolipids, coenzyme Q10 and microencapsulated NADH could affect fatigue levels in long-term patients with intractable fatigue. Fatigue was determined by the validated Piper Fatigue Scale before, [...]